Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

by Compuscript LtdGraphical abstract. Credit:Acta Pharmaceutica Sinica B(2022). DOI: 10.1016/j.apsb.2022.08.006A new article published inActa Pharmaceutica Sinica Bdiscusses ho

Updated on: January 30,2024

Study: Anti-PD-L1 antibody enhances curative effect of cryoablation

by Compuscript LtdGraphical abstract. Credit:Acta Pharmaceutica Sinica B(2022). DOI: 10.1016/j.apsb.2022.08.006A new article published inActa Pharmaceutica Sinica Bdiscusses ho

Updated on:January 30,2024

Exploring ferroptosis and its implications in lung cancer

by Cactus CommunicationsEven with advances in diagnosis and treatments, the survival rate of patients with lung cancer, remains to be low. Ferroptosis is a type of iron-dependent programmed cell death

Updated on: March 30,2024

Exploring ferroptosis and its implications in lung cancer

by Cactus CommunicationsEven with advances in diagnosis and treatments, the survival rate of patients with lung cancer, remains to be low. Ferroptosis is a type of iron-dependent programmed cell death

Updated on:March 30,2024

Social media can boost melanoma detection, research suggests

by Leila Okahata,University of OregonExamples of knowledge, self-efficacy, and control messages. Credit:JID Innovations(2023). DOI: 10.1016/j.xjidi.2023.100253Early detection is key

Updated on: March 30,2024

Social media can boost melanoma detection, research suggests

by Leila Okahata,University of OregonExamples of knowledge, self-efficacy, and control messages. Credit:JID Innovations(2023). DOI: 10.1016/j.xjidi.2023.100253Early detection is key

Updated on:March 30,2024

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th

Updated on: February 18,2024

Study identifies a potential therapeutic target for triple-negative breast cancer in Black patients

by Adam Pope,University of Alabama at BirminghamProtein diversity due to alternative mRNA splicing or post-translational modifications (PTMs) plays a vital role in various cellular functions. Th

Updated on:February 18,2024

Beating cancer-related fatigue with personalized interventions

byUniversity of TwenteFlow diagram of selection of eligible studies. Credit:European Journal of Cancer Care(2022). DOI: 10.1111/ecc.13754After diagnosis and treatment of breast cance

Updated on: January 07,2024

Beating cancer-related fatigue with personalized interventions

byUniversity of TwenteFlow diagram of selection of eligible studies. Credit:European Journal of Cancer Care(2022). DOI: 10.1111/ecc.13754After diagnosis and treatment of breast cance

Updated on:January 07,2024

Severe herpesvirus infection beats adult T-cell leukemia/lymphoma

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn a recently published editorial in the journalGenes & Cancer, researcher Tatsuro Jo from the Japanese Red Cross Nagasaki Genbaku Hosp

Updated on: January 16,2024

Severe herpesvirus infection beats adult T-cell leukemia/lymphoma

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainIn a recently published editorial in the journalGenes & Cancer, researcher Tatsuro Jo from the Japanese Red Cross Nagasaki Genbaku Hosp

Updated on:January 16,2024

Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

byUniversity of Texas M. D. Anderson Cancer CenterCAR-NK cells have a distinct single-cell transcriptome and metabolic profile. Credit:Science Advances(2023). DOI: 10.1126/sciadv.add

Updated on: January 23,2024

Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

byUniversity of Texas M. D. Anderson Cancer CenterCAR-NK cells have a distinct single-cell transcriptome and metabolic profile. Credit:Science Advances(2023). DOI: 10.1126/sciadv.add

Updated on:January 23,2024

A novel strategy to suppress triple negative breast cancer growth

by Homa Shalchi,Baylor College of MedicineCredit:PLOS Biology(2023). DOI: 10.1371/journal.pbio.3002227In 2022, a team of researchers at Baylor College of Medicinediscovered&nbs

Updated on: February 01,2024

A novel strategy to suppress triple negative breast cancer growth

by Homa Shalchi,Baylor College of MedicineCredit:PLOS Biology(2023). DOI: 10.1371/journal.pbio.3002227In 2022, a team of researchers at Baylor College of Medicinediscovered&nbs

Updated on:February 01,2024

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on: January 30,2024

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong

Updated on:January 30,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on: January 30,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on:January 30,2024

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on: August 03,2024

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Updated on:August 03,2024

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on: April 07,2024

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on:April 07,2024